Jian Li Campian.jpg

Jian Li Campian, MD, PhD

Assistant Professor
Department of Medicine
Oncology Division
Medical Oncology
Department of Neurological Surgery

Clinical Interests

  • Brain tumors

Research Interests

  • Neuro-oncology:
  • - Immunotherapy
  • - Target therapy
  • - Early phase clinic trial development


  • 314-362-5677 (tel)
  • 314-362-7086 (fax)
  • 11th Floor Mid-Campus Center (office)
  • Division of Oncology
    Campus Box 8056
    Washington University Medical School
    660 South Euclid Avenue
    St. Louis, MO 63110


Dr. Campian's research focus is immunotherapy and new drug development in high grade gliomas. Dr. Campian and her colleagues have demonstrated that treatment-related lymphopenia is common, severe and long lasting in various solid tumors including glioblastoma, pancreatic cancer, non-small cell lung cancer, head and neck squamous carcinoma, rectal cancer, etc. More importantly, this treatment-related lymphopenia is associated with inferior survival and patients died from tumor progression not opportunistic infections. Thus, her research has been focused on how to correct treatment-related lymphopenia in patients with malignant brain tumors, with an ultimate goal to improve overall survival in this deadly disease. She is currently the study chair for a multi-center study to evaluate whether interleukin-7 can increase CD4+ cell counts and correct treatment-related lymphopenia in patients with high grade gliomas who require standard chemoradiation.